126 related articles for article (PubMed ID: 34887174)
1. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
Schullian P; Johnston E; Laimer G; Scharll Y; Putzer D; Eberle G; Kolbitsch C; Amann A; Stättner S; Bale R
HPB (Oxford); 2022 Jul; 24(7):1044-1054. PubMed ID: 34887174
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
[TBL] [Abstract][Full Text] [Related]
5. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Scharll Y; Widmann G; Kolbitsch C; Bale R
Int J Hyperthermia; 2022; 39(1):421-430. PubMed ID: 35227136
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Wang YB; Zhang H; Huo L; Xing BC; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):292-6. PubMed ID: 15968323
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
Schullian P; Putzer D; Laimer G; Levy E; Bale R
Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiofrequency ablation of a variety of liver masses in children.
Hetzer B; Vogel GF; Entenmann A; Heil M; Schullian P; Putzer D; Meister B; Crazzolara R; Kropshofer G; Salvador C; Straub S; Karall D; Niederwanger C; Cortina G; Janecke A; Freund-Unsinn K; Maurer K; Schweigmann G; Oberhuber G; Renz O; Schneeberger S; Müller T; Bale R
Int J Hyperthermia; 2020; 37(1):1074-1081. PubMed ID: 32954876
[TBL] [Abstract][Full Text] [Related]
9. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Amann A; Effenberger M; Maglione M; Freund MC; Loizides A; Bale R
Eur Radiol; 2021 May; 31(5):3042-3052. PubMed ID: 33125554
[TBL] [Abstract][Full Text] [Related]
10. Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Westerlund P; Henninger B; Bale R
Int J Hyperthermia; 2020; 37(1):564-572. PubMed ID: 32484004
[No Abstract] [Full Text] [Related]
11. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
[No Abstract] [Full Text] [Related]
12. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Widmann G; Schullian P; Haidu M; Bale R
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy.
Schullian P; Putzer D; Eberle G; Laimer G; Bale R
J Vasc Interv Radiol; 2020 Jun; 31(6):943-952. PubMed ID: 32414570
[TBL] [Abstract][Full Text] [Related]
16. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Yang Y; Yu H; Tan X; You Y; Liu F; Zhao T; Qi J; Li J; Feng Y; Zhu Q
Int J Hyperthermia; 2021; 38(1):875-886. PubMed ID: 34078221
[TBL] [Abstract][Full Text] [Related]
17. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation combined with transarterial chemoembolization in treatment of hepatocellular carcinoma adjacent to the second hepatic hilus.
Chen ML; Li HL; Guo CY; Zhang H; Yuan H; Li Z; Park JH; Hu HT
Abdom Radiol (NY); 2022 Jan; 47(1):423-430. PubMed ID: 34635940
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Scharll Y; Ianetti-Hackl C; Bale R
Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1184-1193. PubMed ID: 33825059
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
